WNT5A enhances resistance of melanoma cells to targeted BRAF inhibitors-Reference-Cited by-同舟云学术

WNT5A enhances resistance of melanoma cells to targeted BRAF inhibitors

Published:2014-05-27 Issue:7 Volume:124 Page:2877-2890
ISSN:0021-9738
Container-title:Journal of Clinical Investigation
language:en
Short-container-title:J. Clin. Invest.

Author:

Anastas Jamie N.,Kulikauskas Rima M.,Tamir Tigist,Rizos Helen,Long Georgina V.,von Euw Erika M.,Yang Pei-Tzu,Chen Hsiao-Wang,Haydu Lauren,Toroni Rachel A.,Lucero Olivia M.,Chien Andy J.,Moon Randall T.

Publisher

American Society for Clinical Investigation

Subject

General Medicine

Reference70 articles.

1. Mutations of the BRAF gene in human cancer

2. Distinct Sets of Genetic Alterations in Melanoma

3. Discovery of a selective inhibitor of oncogenic B-Raf kinase with potent antimelanoma activity

4. The RAF inhibitor PLX4032 inhibits ERK signaling and tumor cell proliferation in a V600E BRAF-selective manner

5. Inhibition of Mutated, Activated BRAF in Metastatic Melanoma

Cited by 147 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Targeted Therapy Innovations for Melanoma;Hematology/Oncology Clinics of North America;2024-10

2. Molecular Susceptibility and Treatment Challenges in Melanoma;Cells;2024-08-20

3. Unraveling Cancer’s Wnt Signaling: Dynamic Control through Protein Kinase Regulation;Cancers;2024-07-28

4. Identification of BRAF Inhibitor Resistance–associated lncRNAs Using Genome-scale CRISPR-Cas9 Transcriptional Activation Screening;Anticancer Research;2024-05-31

5. Antibody dependent cellular cytotoxicity-inducing anti-EGFR antibodies as effective therapeutic option for cutaneous melanoma resistant to BRAF inhibitors;Frontiers in Immunology;2024-03-06